B
Bertis
A proteomics-based molecular diagnostics company focused on the discovery of cancer-related biomarkers
About Bertis
Bertis is a pioneering company in the field of proteomics-based precision medicine, specializing in advanced mass spectrometry analysis services. The company serves clients in academia, biotechnology, and pharmaceuticals, offering tailored solutions that meet the specific needs of research and development in these sectors. Operating primarily in the Asian market, Bertis leverages its proprietary technologies to provide high-quality omics analysis, which includes the renewed Pan-omics Analysis Service Solution (PASS). This service is optimized for detailed and accurate analysis, requiring a minimum sample quantity and specific conditions to ensure precise results. Bertis generates revenue through its specialized services, which are essential for cutting-edge research in early cancer diagnostics and other medical innovations. The company’s business model focuses on providing high-value, technology-driven solutions that address critical challenges in medical research and diagnostics.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Seongnam-si, South Korea
- Employees
- 38
- Open positions
- None listed
- Dealroom signal
- 69.9/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Spinout, Biotech and Pharma, proteomics, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Feb 2024 | $17M | $67M | Korea Development Bank · BNH Investment · Winvest Venture Partners · Premier Partners | ↗ |
| LATE VC✓Equity / VC | Jun 2021 | $0 | — | SK Planet · SK Telecom | — |
Growth signals
Latest recorded traffic for Bertis is 2.1K monthly website visits, down 19.2% over the last three months. Bertis's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later13 investors entered at this stage
- BIBNH Investment
- KIKCLAVIS Investment
Premier Partners
SmileGate Investment
NH Investment & Securities
Focus Assets Management- MIMeritz Fire & Marine Insurance
- DPDreamstone Partners
SK Planet
SK Telecom
Korea Development Bank- WPWinvest Venture Partners
DreamCIS
Other known investors2 additional known investors
Seoul National University
Seoul National University Hospital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bertis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bertis’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.